Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome After Radical Gastrectomy
A clinical trial update describing a metabolomics-based study to understand why metabolic syndrome may remit after radical gastrectomy, with…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer [Phase 2]
This is a single-arm Phase II clinical trial evaluating the efficacy and safety of combining Paclitaxel Polymeric Micelles for Injection wit…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.
A completed clinical study evaluating whether changes in the Systemic Immune-Inflammation Index predict outcomes in patients with gastric ca…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy [Phase 1, Phase 2]
Clinical trial update indicating ongoing recruitment for a Phase 1/2 study of trastuzumab, bevacizumab, and paclitaxel in HER2-positive adva…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer
This clinical trial investigates how blood levels of sintilimab relate to its efficacy and adverse effects in patients with advanced gastric…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: The Number of Mesogastria Containing Metastatic Lymph Nodes Predicts Gastric Cancer Prognosis
A completed clinical trial update suggests that the number of mesogastric lymph nodes containing metastases may predict prognosis in gastric…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Study of NDI 1150-101 in Patients With Solid Tumors [Phase 1, Phase 2]
Nimbus Saturn, Inc. is conducting a Phase 1/2 trial of NDI 1150-101 in patients with solid tumors, including renal cell carcinoma, gastric c…
-
FDA approval · 2024-11-22FDA Approved: PHESGO — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for PHESGO, the fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf, submitted…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens [Phase 2]
Phase 2 study evaluating trastuzumab deruxtecan monotherapy in HER2-expressing gastric or GEJ adenocarcinoma after two or more prior regimen…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Validation of a Model for Predicting Anastomotic Leakage
Completed study validating a predictive model for anastomotic leakage following gastric cancer surgery.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
An update on an ongoing gastric cancer study that analyzes tumor morphology, microenvironment, immunity, and patient expectations to predict…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGC
This clinical trial update assesses the impact of TTC after neoadjuvant chemotherapy on prognosis in locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma [Phase 1]
This clinical trial update notes the completion of a Phase 1 pharmacokinetic study of zolbetuximab (IMAB362) in Chinese patients with locall…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Study of IBI363 in Patients with Advanced First-line Gastric Cancer [Phase 1]
A Phase 1 trial evaluating IBI363 in combination with chemotherapy for first-line advanced gastric cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer [Phase 2]
A Phase 2 trial update evaluating liposomal irinotecan with sintilimab as second-line therapy for progressive gastric cancer; the study is n…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: The Incidence of Gallstones After Gastrectomy [NA]
A completed clinical trial reports the incidence of gallstones after gastrectomy in patients with gastric cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: The Incidence of Gallstones After Gastric Cancer Surgery
A completed study assessed the incidence of gallstones after gastric cancer surgery. The trial was sponsored by the Hepatopancreatobiliary S…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: A Phase 2 Clinical Study of ABSK061 and ABSK043 [Phase 2]
Abbisko Therapeutics is recruiting for a Phase 2 study of ABSK061 and ABSK043 in multiple cancers, including HER2-positive gastric/gastroeso…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer
This clinical trial update shows that a rehabilitation and recovery program for persons with esophageal or gastric cancer is currently recru…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer [Phase 1]
Phase 1 study assessing safety and activity of IMAB362 (zolbetuximab) in combination with zoledronic acid and interleukin-2 in CLDN18.2-posi…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Appraisal of the Modified Cancer Cachexia Index in Locally Advanced Gastric Cancer Patients Undergoing Neoadjuvant Chemotherapy
Completed clinical study evaluating the Modified Cancer Cachexia Index in locally advanced gastric cancer patients undergoing neoadjuvant ch…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ) [Phase 2]
A Phase 2 trial evaluating atezolizumab plus tiragolumab with chemotherapy in first-line HER2-negative unresectable, recurrent, or metastati…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Anastomotic Leak Testing in Gastrectomy [NA]
This is a completed clinical trial update from Nanchong Central Hospital. It concerns testing for anastomotic leak after gastrectomy in pati…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma [NA]
This clinical trial update reports the completion of a study evaluating tumor treating fields in combination with chemotherapy as first-line…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis. [NA]
A clinical trial at National Cheng-Kung University Hospital is examining whether probiotics can regulate microRNA during H. pylori–induced g…